Net profit of Suven Pharmaceuticals rose 3.33% to Rs 82.21 crore in the quarter ended September 2024 as against Rs 79.56 crore during the previous quarter ended September 2023. Sales rose 11.54% to Rs 257.72 crore in the quarter ended September 2024 as against Rs 231.05 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 257.72 | 231.05 | 12 |
| OPM % | 40.36 | 42.40 | - |
| PBDT | 116.46 | 117.30 | -1 |
| PBT | 99.50 | 105.41 | -6 |
| NP | 82.21 | 79.56 | 3 |